NCT01258309 - Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis | Biotech Hunter

Enrollment

129

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Rhinitis, Allergic, SeasonalConjunctivitis, Allergic

Interventions

DRUG

olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution

One drop of olopatadine hydrochloride/ketorolac tromethamine fixed dose combination ophthalmic solution administered to each eye, twice daily for 21 days.

DRUG

olopatadine hydrochloride 0.1% ophthalmic solution

One drop of olopatadine hydrochloride 0.1% ophthalmic solution administered to each eye, twice daily for 21 days.

Trial Locations (1)

Unknown

Bangalore